| Bryan Jacob Wohlfeld, MD | |
|
719 W 2nd St, Bloomington, IN 47403-2209 | |
| (812) 676-4730 | |
| (812) 676-4731 |
| Full Name | Bryan Jacob Wohlfeld |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 20 Years |
| Location | 719 W 2nd St, Bloomington, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669674081 | NPI | - | NPPES |
| 297763901 | Medicaid | TX | |
| TXB134441 | Other | TX | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 01084250A (Indiana) | Primary |
| 207T00000X | Neurological Surgery | N7764 (Texas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health Bloomington Hospital | Bloomington, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana University Health Southern Indiana Physicians Llc | 6204748197 | 449 |
News Archive
A joint research effort between researchers at the Burnham Institute for Medical Research in La Jolla, CA, and a team from Japan (Iwate University, Osaka City University, Gifu University, Iwate Medical University) has discovered a novel way to treat stroke and neurodegenerative disorders.
Visual Healthcare Corp. announces that its new Lab Automation module is quickly gaining traction with private sector industrial clients.
A new study published in the journal Drug Testing and Analysis found that DMAA, a stimulant often found in many nutritional and sports supplements, does not originate from natural substances and is actually comprised of synthetic compounds.
A population-based analysis of more than 3,000 families including women with breast cancer has found that close relatives of women who carry mutations in a BRCA gene - but who themselves do not have such genetic mutations - do not have an increased risk of developing breast cancer compared to relatives of women with breast cancer who do not have such mutations.
Phosphagenics Limited today announced the initiation of a Phase 1B clinical trial for its patented oxycodone/TPM (Targeted Penetration Matrix) transdermal patch systems.
› Verified 1 days ago
| Entity Name | Indiana University Health Southern Indiana Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013953983 PECOS PAC ID: 6204748197 Enrollment ID: O20040423000556 |
News Archive
A joint research effort between researchers at the Burnham Institute for Medical Research in La Jolla, CA, and a team from Japan (Iwate University, Osaka City University, Gifu University, Iwate Medical University) has discovered a novel way to treat stroke and neurodegenerative disorders.
Visual Healthcare Corp. announces that its new Lab Automation module is quickly gaining traction with private sector industrial clients.
A new study published in the journal Drug Testing and Analysis found that DMAA, a stimulant often found in many nutritional and sports supplements, does not originate from natural substances and is actually comprised of synthetic compounds.
A population-based analysis of more than 3,000 families including women with breast cancer has found that close relatives of women who carry mutations in a BRCA gene - but who themselves do not have such genetic mutations - do not have an increased risk of developing breast cancer compared to relatives of women with breast cancer who do not have such mutations.
Phosphagenics Limited today announced the initiation of a Phase 1B clinical trial for its patented oxycodone/TPM (Targeted Penetration Matrix) transdermal patch systems.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bryan Jacob Wohlfeld, MD Po Box 845347, Dallas, TX 75284-5347 Ph: (214) 645-2300 | Bryan Jacob Wohlfeld, MD 719 W 2nd St, Bloomington, IN 47403-2209 Ph: (812) 676-4730 |
News Archive
A joint research effort between researchers at the Burnham Institute for Medical Research in La Jolla, CA, and a team from Japan (Iwate University, Osaka City University, Gifu University, Iwate Medical University) has discovered a novel way to treat stroke and neurodegenerative disorders.
Visual Healthcare Corp. announces that its new Lab Automation module is quickly gaining traction with private sector industrial clients.
A new study published in the journal Drug Testing and Analysis found that DMAA, a stimulant often found in many nutritional and sports supplements, does not originate from natural substances and is actually comprised of synthetic compounds.
A population-based analysis of more than 3,000 families including women with breast cancer has found that close relatives of women who carry mutations in a BRCA gene - but who themselves do not have such genetic mutations - do not have an increased risk of developing breast cancer compared to relatives of women with breast cancer who do not have such mutations.
Phosphagenics Limited today announced the initiation of a Phase 1B clinical trial for its patented oxycodone/TPM (Targeted Penetration Matrix) transdermal patch systems.
› Verified 1 days ago
Dr. Todd A Eads, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 719 W 2nd St, Bloomington, IN 47403 Phone: 317-396-1300 Fax: 317-329-3040 | |
Kevin J Powers, DPM Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1791 W 3rd St, Bloomington, IN 47404 Phone: 812-333-4422 Fax: 812-333-6698 |